These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 16030279)

  • 1. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
    Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
    JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients.
    Haase M; Haase-Fielitz A; Bagshaw SM; Reade MC; Morgera S; Seevenayagam S; Matalanis G; Buxton B; Doolan L; Bellomo R
    Crit Care Med; 2007 May; 35(5):1324-31. PubMed ID: 17414730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.
    ; Alexander JH; Emery RW; Carrier M; Ellis SJ; Mehta RH; Hasselblad V; Menasche P; Khalil A; Cote R; Bennett-Guerrero E; Mack MJ; Schuler G; Harrington RA; Tardif JC
    JAMA; 2008 Apr; 299(15):1777-87. PubMed ID: 18381567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
    Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
    JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery.
    Wijeysundera DN; Karkouti K; Rao V; Granton JT; Chan CT; Raban R; Carroll J; Poonawala H; Beattie WS
    Crit Care Med; 2009 Jun; 37(6):1929-34. PubMed ID: 19384218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
    Mitchell LB; Exner DV; Wyse DG; Connolly CJ; Prystai GD; Bayes AJ; Kidd WT; Kieser T; Burgess JJ; Ferland A; MacAdams CL; Maitland A
    JAMA; 2005 Dec; 294(24):3093-100. PubMed ID: 16380589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
    Song JW; Shim JK; Soh S; Jang J; Kwak YL
    Nephrology (Carlton); 2015 Feb; 20(2):96-102. PubMed ID: 25384603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
    Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G
    Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pre- and postoperative renal dysfunction on outcome of patients undergoing coronary artery bypass grafting (CABG).
    Litmathe J; Kurt M; Feindt P; Gams E; Boeken U
    Thorac Cardiovasc Surg; 2009 Dec; 57(8):460-3. PubMed ID: 20013618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study.
    Hudetz JA; Iqbal Z; Gandhi SD; Patterson KM; Byrne AJ; Pagel PS
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):811-6. PubMed ID: 20655248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.
    Tolpin DA; Collard CD; Lee VV; Elayda MA; Pan W
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):873-9. PubMed ID: 19660351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.
    Mentzer RM; Oz MC; Sladen RN; Graeve AH; Hebeler RF; Luber JM; Smedira NG;
    J Am Coll Cardiol; 2007 Feb; 49(6):716-26. PubMed ID: 17291938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of coronary artery bypass operations in patients with renal insufficiency with and without renal transplantation.
    Massad MG; Kpodonu J; Lee J; Espat J; Gandhi S; Tevar A; Geha AS
    Chest; 2005 Aug; 128(2):855-62. PubMed ID: 16100178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
    Newman MF; Ferguson TB; White JA; Ambrosio G; Koglin J; Nussmeier NA; Pearl RG; Pitt B; Wechsler AS; Weisel RD; Reece TL; Lira A; Harrington RA;
    JAMA; 2012 Jul; 308(2):157-64. PubMed ID: 22782417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
    Verrier ED; Shernan SK; Taylor KM; Van de Werf F; Newman MF; Chen JC; Carrier M; Haverich A; Malloy KJ; Adams PX; Todaro TG; Mojcik CF; Rollins SA; Levy JH;
    JAMA; 2004 May; 291(19):2319-27. PubMed ID: 15150203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction.
    Weerasinghe A; Hornick P; Smith P; Taylor K; Ratnatunga C
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1083-9. PubMed ID: 11385375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.